Literature DB >> 24838199

Review: interstitial lung disease associated with systemic sclerosis and idiopathic pulmonary fibrosis: how similar and distinct?

Erica L Herzog1, Aditi Mathur, Andrew M Tager, Carol Feghali-Bostwick, Frank Schneider, John Varga.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24838199      PMCID： PMC4340472          DOI： 10.1002/art.38702

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN： 2326-5191            Impact factor:   10.995


× No keyword cloud information.
  78 in total

1.  Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial.

Authors:  Ganesh Raghu; Kevin K Brown; Ulrich Costabel; Vincent Cottin; Roland M du Bois; Joseph A Lasky; Michiel Thomeer; James P Utz; Rezaul K Khandker; Lawrence McDermott; Saeed Fatenejad
Journal:  Am J Respir Crit Care Med       Date:  2008-07-31       Impact factor: 21.405

2.  2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

Authors:  Frank van den Hoogen; Dinesh Khanna; Jaap Fransen; Sindhu R Johnson; Murray Baron; Alan Tyndall; Marco Matucci-Cerinic; Raymond P Naden; Thomas A Medsger; Patricia E Carreira; Gabriela Riemekasten; Philip J Clements; Christopher P Denton; Oliver Distler; Yannick Allanore; Daniel E Furst; Armando Gabrielli; Maureen D Mayes; Jacob M van Laar; James R Seibold; Laszlo Czirjak; Virginia D Steen; Murat Inanc; Otylia Kowal-Bielecka; Ulf Müller-Ladner; Gabriele Valentini; Douglas J Veale; Madelon C Vonk; Ulrich A Walker; Lorinda Chung; David H Collier; Mary Ellen Csuka; Barri J Fessler; Serena Guiducci; Ariane Herrick; Vivien M Hsu; Sergio Jimenez; Bashar Kahaleh; Peter A Merkel; Stanislav Sierakowski; Richard M Silver; Robert W Simms; John Varga; Janet E Pope
Journal:  Arthritis Rheum       Date:  2013-10-03

Review 3.  Scleroderma lung disease.

Authors:  Joshua J Solomon; Amy L Olson; Aryeh Fischer; Todd Bull; Kevin K Brown; Ganesh Raghu
Journal:  Eur Respir Rev       Date:  2013-03-01

4.  Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.

Authors:  Stephen C Mathai; Laura K Hummers; Hunter C Champion; Fredrick M Wigley; Ari Zaiman; Paul M Hassoun; Reda E Girgis
Journal:  Arthritis Rheum       Date:  2009-02

5.  Plasma B lymphocyte stimulator and B cell differentiation in idiopathic pulmonary fibrosis patients.

Authors:  Jianmin Xue; Daniel J Kass; Jessica Bon; Louis Vuga; Jiangning Tan; Eva Csizmadia; Leo Otterbein; Makoto Soejima; Marc C Levesque; Kevin F Gibson; Naftali Kaminski; Joseph M Pilewski; Michael Donahoe; Frank C Sciurba; Steven R Duncan
Journal:  J Immunol       Date:  2013-07-19       Impact factor: 5.422

6.  Prediction of pulmonary complications and long-term survival in systemic sclerosis.

Authors:  Svetlana I Nihtyanova; Benjamin E Schreiber; Voon H Ong; Daniel Rosenberg; Pia Moinzadeh; J Gerrard Coghlan; Athol U Wells; Christopher P Denton
Journal:  Arthritis Rheumatol       Date:  2014-06       Impact factor: 10.995

7.  Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial.

Authors:  Ganesh Raghu; Juergen Behr; Kevin K Brown; Jim J Egan; Steven M Kawut; Kevin R Flaherty; Fernando J Martinez; Steven D Nathan; Athol U Wells; Harold R Collard; Ulrich Costabel; Luca Richeldi; Joao de Andrade; Nasreen Khalil; Lake D Morrison; David J Lederer; Lixin Shao; Xiaoming Li; Patty S Pedersen; A Bruce Montgomery; Jason W Chien; Thomas G O'Riordan
Journal:  Ann Intern Med       Date:  2013-05-07       Impact factor: 25.391

8.  A multidimensional index and staging system for idiopathic pulmonary fibrosis.

Authors:  Brett Ley; Christopher J Ryerson; Eric Vittinghoff; Jay H Ryu; Sara Tomassetti; Joyce S Lee; Venerino Poletti; Matteo Buccioli; Brett M Elicker; Kirk D Jones; Talmadge E King; Harold R Collard
Journal:  Ann Intern Med       Date:  2012-05-15       Impact factor: 25.391

9.  Effect and safety of mycophenolate mofetil in idiopathic pulmonary fibrosis.

Authors:  Argyris Tzouvelekis; Evangelos Bouros; Anastasia Oikonomou; Paschalis Ntolios; George Zacharis; George Kolios; Demosthenes Bouros
Journal:  Pulm Med       Date:  2011-11-01

10.  Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease.

Authors:  Gisela E Lindahl; Carmel Jw Stock; Xu Shi-Wen; Patricia Leoni; Piersante Sestini; Sarah L Howat; George Bou-Gharios; Andrew G Nicholson; Christopher P Denton; Jan C Grutters; Toby M Maher; Athol U Wells; David J Abraham; Elisabetta A Renzoni
Journal:  Respir Res       Date:  2013-08-02
View more
  65 in total

1.  New Applications of Old Drugs as Novel Therapies in Idiopathic Pulmonary Fibrosis. Metformin, Hydroxychloroquine, and Thyroid Hormone.

Authors:  Edward P Manning; Ashley Losier; Nkiruka Emeagwali; Changwan Ryu; Shyoko Honiden
Journal:  Am J Respir Crit Care Med       Date:  2019-06-15       Impact factor: 21.405

2.  Sirtuin1 Protects against Systemic Sclerosis-related Pulmonary Fibrosis by Decreasing Proinflammatory and Profibrotic Processes.

Authors:  Haiyan Chu; Shuai Jiang; Qingmei Liu; Yanyun Ma; Xiaoxia Zhu; Minrui Liang; Xiangguang Shi; Weifeng Ding; Xiaodong Zhou; Hejian Zou; Feng Qian; Philip W Shaul; Li Jin; Jiucun Wang
Journal:  Am J Respir Cell Mol Biol       Date:  2018-01       Impact factor: 6.914

3.  Regulatory T Cells in Idiopathic Pulmonary Fibrosis: Too Much of a Good Thing?

Authors:  Meagan W Moore; Erica L Herzog
Journal:  Am J Pathol       Date:  2016-06-23       Impact factor: 4.307

4.  Plexin C1 deficiency permits synaptotagmin 7-mediated macrophage migration and enhances mammalian lung fibrosis.

Authors:  Xueyan Peng; Meagan Moore; Aditi Mathur; Yang Zhou; Huanxing Sun; Ye Gan; Jose D Herazo-Maya; Naftali Kaminski; Xinyuan Hu; Hongyi Pan; Changwan Ryu; Awo Osafo-Addo; Robert J Homer; Carol Feghali-Bostwick; Wassim H Fares; Mridu Gulati; Buqu Hu; Chun-Geun Lee; Jack A Elias; Erica L Herzog
Journal:  FASEB J       Date:  2016-09-08       Impact factor: 5.191

Review 5.  Systemic sclerosis-associated fibrosis: an accelerated aging phenotype?

Authors:  Tracy R Luckhardt; Victor J Thannickal
Journal:  Curr Opin Rheumatol       Date:  2015-11       Impact factor: 5.006

6.  Extracellular Mitochondrial DNA Is Generated by Fibroblasts and Predicts Death in Idiopathic Pulmonary Fibrosis.

Authors:  Changwan Ryu; Huanxing Sun; Mridu Gulati; Jose D Herazo-Maya; Yonglin Chen; Awo Osafo-Addo; Caitlin Brandsdorfer; Julia Winkler; Christina Blaul; Jaden Faunce; Hongyi Pan; Tony Woolard; Argyrios Tzouvelekis; Danielle E Antin-Ozerkis; Jonathan T Puchalski; Martin Slade; Anjelica L Gonzalez; Daniel F Bogenhagen; Varvara Kirillov; Carol Feghali-Bostwick; Kevin Gibson; Kathleen Lindell; Raimund I Herzog; Charles S Dela Cruz; Wajahat Mehal; Naftali Kaminski; Erica L Herzog; Glenda Trujillo
Journal:  Am J Respir Crit Care Med       Date:  2017-12-15       Impact factor: 21.405

Review 7.  Diagnosis and Management of Systemic Sclerosis: A Practical Approach.

Authors:  Jason J Lee; Janet E Pope
Journal:  Drugs       Date:  2016-02       Impact factor: 9.546

8.  Netrin-1 Regulates Fibrocyte Accumulation in the Decellularized Fibrotic Sclerodermatous Lung Microenvironment and in Bleomycin-Induced Pulmonary Fibrosis.

Authors:  Huanxing Sun; Yangyang Zhu; Hongyi Pan; Xiaosong Chen; Jenna L Balestrini; TuKiet T Lam; Jean E Kanyo; Anne Eichmann; Mridu Gulati; Wassim H Fares; Hanwen Bai; Carol A Feghali-Bostwick; Ye Gan; Xueyan Peng; Meagan W Moore; Eric S White; Parid Sava; Anjelica L Gonzalez; Yuwei Cheng; Laura E Niklason; Erica L Herzog
Journal:  Arthritis Rheumatol       Date:  2016-05       Impact factor: 10.995

9.  Endothelial Cells Expressing Endothelial and Mesenchymal Cell Gene Products in Lung Tissue From Patients With Systemic Sclerosis-Associated Interstitial Lung Disease.

Authors:  Fabian A Mendoza; Sonsoles Piera-Velazquez; John L Farber; Carol Feghali-Bostwick; Sergio A Jiménez
Journal:  Arthritis Rheumatol       Date:  2016-01       Impact factor: 10.995

Review 10.  Management of connective tissue diseases associated interstitial lung disease: a review of the published literature.

Authors:  Beth Wallace; Dharshan Vummidi; Dinesh Khanna
Journal:  Curr Opin Rheumatol       Date:  2016-05       Impact factor: 5.006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.